ZA975533B - Cyclosporin-containing pharmaceutical composition. - Google Patents
Cyclosporin-containing pharmaceutical composition.Info
- Publication number
- ZA975533B ZA975533B ZA9705533A ZA975533A ZA975533B ZA 975533 B ZA975533 B ZA 975533B ZA 9705533 A ZA9705533 A ZA 9705533A ZA 975533 A ZA975533 A ZA 975533A ZA 975533 B ZA975533 B ZA 975533B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyclosporin
- pharmaceutical composition
- containing pharmaceutical
- composition
- pharmaceutical
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
- 229930105110 Cyclosporin A Natural products 0.000 title 1
- 108010036949 Cyclosporine Proteins 0.000 title 1
- 229960001265 ciclosporin Drugs 0.000 title 1
- 229930182912 cyclosporin Natural products 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019960030726A KR980008239A (ko) | 1996-07-26 | 1996-07-26 | 사이클로스포린-함유 약학적 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA975533B true ZA975533B (en) | 1998-01-29 |
Family
ID=19467724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9705533A ZA975533B (en) | 1996-07-26 | 1997-06-23 | Cyclosporin-containing pharmaceutical composition. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5980939A (fr) |
| KR (2) | KR980008239A (fr) |
| AU (1) | AU3049397A (fr) |
| WO (1) | WO1997036610A1 (fr) |
| ZA (1) | ZA975533B (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858401A (en) * | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
| US5958876A (en) * | 1996-06-19 | 1999-09-28 | Novartis Ag | Cyclosporin-containing pharmaceutical compositions |
| US6258783B1 (en) * | 1997-04-29 | 2001-07-10 | Bernard Charles Sherman | Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride |
| NZ314702A (en) * | 1997-04-29 | 1998-07-28 | Bernard Charles Sherman | Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent |
| KR19990047897A (ko) * | 1997-12-05 | 1999-07-05 | 김충환 | 사이클로스포린 함유 약학적 조성물 |
| ATE497384T1 (de) | 1997-12-10 | 2011-02-15 | Cyclosporine Therapeutics Ltd | Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen |
| ID25908A (id) * | 1998-03-06 | 2000-11-09 | Novartis Ag | Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida |
| US6979456B1 (en) | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| CA2331640A1 (fr) * | 1998-05-07 | 1999-11-11 | Elan Corporation Plc | Systemes d'apport de medicament de preconcentre de microemulsion et d'emulsion depourvues de solvant/cosolvant |
| GB9817650D0 (en) * | 1998-08-14 | 1998-10-07 | Danbiosyst Uk | Oral formulation |
| FR2787322B1 (fr) * | 1998-12-18 | 2002-10-18 | Galderma Res & Dev | Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie |
| ATE404172T1 (de) | 1998-12-30 | 2008-08-15 | Dexcel Ltd | Dispergierbares konzentrat zur verabreichung von cyclosporin |
| US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
| GB9912476D0 (en) * | 1999-05-28 | 1999-07-28 | Novartis Ag | Organic compounds |
| US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
| WO2001083698A2 (fr) * | 2000-04-28 | 2001-11-08 | Supratek Pharma, Inc. | Compositions et methodes permettant d'induire l'activation de cellules dendritiques |
| US20070179197A1 (en) * | 2000-05-01 | 2007-08-02 | Accera, Inc. | Compositions and methods for improving or preserving brain function |
| JP2003531857A (ja) * | 2000-05-01 | 2003-10-28 | アクセラ・インコーポレーテッド | アルツハイマー病およびニューロンの代謝の減少によって引き起こされる他の病気を治療および予防するための中鎖トリグリセリドの使用 |
| US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| AU6608701A (en) * | 2000-06-21 | 2002-01-02 | Audit Institute For Medical Services And Quality Assurance Gmbh | Pharmaceutical preparations containing cyclosporines and neutral oils |
| CA2461730C (fr) * | 2001-10-19 | 2012-05-15 | Isotechnika Inc. | Nouveaux preconcentres en microemulsion d'analogues de cyclosporine |
| US7588786B2 (en) * | 2001-11-14 | 2009-09-15 | Jarrow Formulas, Inc. | Eutectic-based self-nanoemulsified drug delivery system |
| US6979672B2 (en) * | 2002-12-20 | 2005-12-27 | Polichem, S.A. | Cyclosporin-based pharmaceutical compositions |
| WO2004077938A2 (fr) * | 2003-03-06 | 2004-09-16 | Accera Inc. | Nouvelles entites chimiques et leurs methodes d'utilisation dans le traitement de troubles du metabolisme |
| EP1670325A1 (fr) | 2003-09-29 | 2006-06-21 | Soft Gel Technologies, Inc. | Coq-10 solubilise |
| US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| US20060252775A1 (en) * | 2005-05-03 | 2006-11-09 | Henderson Samuel T | Methods for reducing levels of disease associated proteins |
| WO2007001883A2 (fr) * | 2005-06-20 | 2007-01-04 | Accera, Inc. | Procédé visant à réduire les dommages oxydatifset à améliorer l’efficacité des mitochondries |
| EP1906949B1 (fr) * | 2005-07-01 | 2015-02-11 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Utilisation de l-carnitine ou de l-carnitines alcanoyle dans la preparation de medicament ou de complement physiologique pour usage ophthalmique sous forme de gouttes ophtalmiques |
| EP2001293B9 (fr) | 2006-04-03 | 2019-04-17 | Accera, Inc. | Utilisation de composés cétogènes pour le traitement des troubles cognitifs liés à l'âge |
| US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
| ES2608286T3 (es) | 2007-07-31 | 2017-04-07 | Accera, Inc. | Uso de ensayos genómicos y compuestos cetogénicos para tratamiento de una función cognitiva reducida |
| EP2200613B1 (fr) | 2007-09-21 | 2018-09-05 | The Johns Hopkins University | Dérivés de phénazine et leurs utilisations |
| MX340897B (es) * | 2007-10-02 | 2016-07-29 | Theranos Inc | Dispositivos modulares de punto de cuidado y usos de los mismos. |
| KR101734152B1 (ko) * | 2008-07-03 | 2017-05-11 | 액세라인크 | 신경계 장애의 치료를 위한 아세토아세테이트의 모노글리세리드 및 유도체 |
| US8105809B2 (en) * | 2008-07-03 | 2012-01-31 | Accera, Inc. | Enzymatic synthesis of acetoacetate esters and derivatives |
| WO2012015211A2 (fr) * | 2010-07-30 | 2012-02-02 | 주식회사종근당 | Composition de gouttes ophtalmiques contenant de la cyclosporine a |
| WO2013074616A1 (fr) * | 2011-11-15 | 2013-05-23 | Allergan, Inc. | Suspensions autoclavables de la forme 2 de cyclosporine a |
| KR101819310B1 (ko) | 2015-12-29 | 2018-01-18 | 단국대학교 천안캠퍼스 산학협력단 | 사이클로스포린을 포함하는 약학 조성물 |
| KR102142916B1 (ko) * | 2018-08-17 | 2020-08-10 | 부산대학교 산학협력단 | 상향식 방법을 통한 난용성 약물을 포함하는 나노현탁액의 제조방법 및 이로 제조된 나노현탁액 |
| KR102822437B1 (ko) | 2022-11-25 | 2025-06-17 | 김효재 | 인버터를 이용한 꿀 농축장치 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146499A (en) * | 1976-09-18 | 1979-03-27 | Rosano Henri L | Method for preparing microemulsions |
| FI65914C (fi) * | 1978-03-07 | 1984-08-10 | Sandoz Ag | Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a |
| US5342625A (en) * | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
| GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| JPH06247869A (ja) * | 1993-02-22 | 1994-09-06 | Dotsuto:Kk | 経気道吸収剤及び経鼻吸収剤 |
| CN1077800C (zh) * | 1993-07-01 | 2002-01-16 | 韩美药品工业株式会社 | 环孢菌素软胶囊组合物 |
| JPH07188046A (ja) * | 1993-12-27 | 1995-07-25 | L T T Kenkyusho:Kk | シクロスポリン含有外用治療薬及びその製造方法 |
| KR0146671B1 (ko) * | 1994-02-25 | 1998-08-17 | 김충환 | 사이클로스포린-함유 분말 조성물 |
| US5603951A (en) * | 1994-11-09 | 1997-02-18 | Hanmi Pharm. Ind. Co., Ltd. | Cyclosporin-containing soft capsule compositions |
| KR100191999B1 (ko) * | 1994-12-28 | 1999-06-15 | 이정국 | 고급 알콜의 제조방법 |
-
1996
- 1996-07-26 KR KR1019960030726A patent/KR980008239A/ko active Pending
-
1997
- 1997-02-14 US US08/801,117 patent/US5980939A/en not_active Expired - Lifetime
- 1997-05-29 KR KR1019980708828A patent/KR100257841B1/ko not_active Expired - Lifetime
- 1997-05-29 WO PCT/KR1997/000098 patent/WO1997036610A1/fr not_active Ceased
- 1997-05-29 AU AU30493/97A patent/AU3049397A/en not_active Abandoned
- 1997-06-23 ZA ZA9705533A patent/ZA975533B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997036610A1 (fr) | 1997-10-09 |
| KR100257841B1 (ko) | 2000-09-01 |
| US5980939A (en) | 1999-11-09 |
| AU3049397A (en) | 1997-10-22 |
| KR19990078523A (ko) | 1999-11-05 |
| KR980008239A (ko) | 1998-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA975533B (en) | Cyclosporin-containing pharmaceutical composition. | |
| ZA9710927B (en) | Pharmaceutical composition. | |
| ZA9710071B (en) | Pharmaceutical composition. | |
| ZA974735B (en) | Pharmaceutical compositions. | |
| ZA965190B (en) | Pharmaceutical composition. | |
| ZA9610070B (en) | Cyclosporin compositions. | |
| ZA967034B (en) | Pharmaceutical compositions. | |
| ZA978178B (en) | Composition. | |
| ZA975261B (en) | Composition. | |
| ZA9811504B (en) | Novel pharmaceutical. | |
| ZA977104B (en) | Pharmaceutical compositions. | |
| ZA9710272B (en) | Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds. | |
| ZA9811506B (en) | Novel pharmaceutical. | |
| ZA989680B (en) | Pharmaceutical composition. | |
| ZA968081B (en) | Pharmaceutical composition. | |
| ZA9811505B (en) | Novel pharmaceutical. | |
| GB9610359D0 (en) | Pharmaceutical compositions | |
| ZA987392B (en) | Pharmaceutical composition. | |
| GB9622681D0 (en) | Pharmaceutical compositions | |
| ZA972602B (en) | Pharmaceutical compositions. | |
| GB9623962D0 (en) | Pharmaceutical composition | |
| GB9613457D0 (en) | Pharmaceutical compositions | |
| GB9618376D0 (en) | Pharmaceutical compositions | |
| ZA982558B (en) | Novel Pharmaceutical. | |
| ZA979447B (en) | Pharmaceutical composition. |